Article

3-D camera 501(k)

The FDA has granted 501(k) approval to Kowa Optimed Inc. for the marketing of its non-mydriatic 3-D retinal camera, the nonmyd WX3D, for simultaneous stereoscopic retinal photography.

Torrance, CA-The FDA has granted 501(k) approval to Kowa Optimed Inc. for the marketing of its non-mydriatic 3-D retinal camera, the nonmyd WX3D, for simultaneous stereoscopic retinal photography.

This new retinal camera brings state-of-the-art simultaneous stereoscopic photography to Kowa’s integrated normal and small pupil settings. The added capability of 3-D photography of the optics disc will enable practitioners to diagnose glaucoma properly.

Kowa is ready for immediate marketing of its nonmydriatic 3-D retinal camera and has scheduled formal launches at both Vision Expo East in New York, March 16 to 20, and at the annual meeting of the American Society of Cataract and Refractive Surgery in San Diego, March 25 to 29.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
© 2025 MJH Life Sciences

All rights reserved.